Favipiravir Bioanalysis [Regulatives / Guidelines]

posted by Ayman Rabayah – Jordan, 2020-08-11 10:44 (2142 d 21:08 ago) – Posting: # 21854
Views: 4,281

Hellow colleagues
Need your feedback about the Bio-analysis of Favipiravir, do the metabolite (Favipiravir RTP) need to be measured or only the Favipiravir, since no FDA or EMEA related guidance issued till date.
Appreciate your thoughts.

Ayman Ahmad

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
136 visitors (0 registered, 136 guests [including 10 identified bots]).
Forum time: 07:52 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5